Home/Filings/4/0001209191-23-059623
4//SEC Filing

Russo Thomas Joseph 4

Accession 0001209191-23-059623

CIK 0001786255other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 6:26 PM ET

Size

7.6 KB

Accession

0001209191-23-059623

Insider Transaction Report

Form 4
Period: 2023-12-20
Russo Thomas Joseph
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2023-12-20$15.46/sh10,753$166,21042,467 total
  • Sale

    Common Stock

    2023-12-20$15.46/sh4,430$68,51038,037 total
Footnotes (4)
  • [F1]Reflects shares sold to cover withholding taxes upon accelerated vesting of restricted stock unit awards pursuant to a Rule10b5-1 instruction letter dated December 6, 2021.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.41 to $15.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Reflects shares sold to cover taxes arising upon accelerated vesting of restricted stock unit awards.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $15.48. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Icosavax, Inc.

CIK 0001786255

Entity typeother

Related Parties

1
  • filerCIK 0001791973

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:26 PM ET
Size
7.6 KB